Bevacizumab for paradoxical worsening treatment adjunct in HIV patient with choroidal tuberculoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-5760
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Bevacizumab for paradoxical worsening treatment adjunct in HIV patient with choroidal tuberculoma ; volume:6 ; number:1 ; day:8 ; month:11 ; year:2016 ; pages:1-3 ; date:12.2016
Journal of ophthalmic inflammation and infection ; 6, Heft 1 (8.11.2016), 1-3, 12.2016
- Urheber
-
Jain, Sahil
- Beteiligte Personen und Organisationen
-
Bajgai, Priya
Tigari, Basavaraj
Sharma, Kusum
Sharma, Aman
Gupta, Vishali
Singh, Ramandeep
SpringerLink (Online service)
- DOI
-
10.1186/s12348-016-0112-1
- URN
-
urn:nbn:de:1111-2016120110139
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jain, Sahil
- Bajgai, Priya
- Tigari, Basavaraj
- Sharma, Kusum
- Sharma, Aman
- Gupta, Vishali
- Singh, Ramandeep
- SpringerLink (Online service)
Ähnliche Objekte (12)
Paradoxical worsening of tuberculous chorioretinitis in a Chinese gentleman
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Worsening angle closure glaucoma and choroidal detachments subsequent to closure of a carotid cavernous fistula
Paradoxical
Polypoidal choroidal vasculopathy—characteristics and response to treatment with bevacizumab in caucasian patients
Treatment response to intravitreal bevacizumab in small pigmented choroidal lesions with subretinal fluid
Angiographic Review of Choroidal Involution in Eyes with Retinopathy of Prematurity Treated with Bevacizumab
Ethnic differences on long term outcomes of polypoidal choroidal vasculopathy after predominantly bevacizumab monotherapy
Paradoxical peeling patterns
Postoperative subconjunctival bevacizumab injection as an adjunct to 5-fluorouracil in the management of scarring after trabeculectomy
Postoperative subconjunctival bevacizumab injection as an adjunct to 5-fluorouracil in the management of scarring after trabeculectomy
Pakistan: the worsening IDP crisis
Paradoxical worsening of tuberculous chorioretinitis in a Chinese gentleman
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Worsening angle closure glaucoma and choroidal detachments subsequent to closure of a carotid cavernous fistula
Paradoxical
Polypoidal choroidal vasculopathy—characteristics and response to treatment with bevacizumab in caucasian patients
Treatment response to intravitreal bevacizumab in small pigmented choroidal lesions with subretinal fluid
Angiographic Review of Choroidal Involution in Eyes with Retinopathy of Prematurity Treated with Bevacizumab
Ethnic differences on long term outcomes of polypoidal choroidal vasculopathy after predominantly bevacizumab monotherapy
Paradoxical peeling patterns
Postoperative subconjunctival bevacizumab injection as an adjunct to 5-fluorouracil in the management of scarring after trabeculectomy
Postoperative subconjunctival bevacizumab injection as an adjunct to 5-fluorouracil in the management of scarring after trabeculectomy
Pakistan: the worsening IDP crisis
Paradoxical worsening of tuberculous chorioretinitis in a Chinese gentleman
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Worsening angle closure glaucoma and choroidal detachments subsequent to closure of a carotid cavernous fistula
Paradoxical
Polypoidal choroidal vasculopathy—characteristics and response to treatment with bevacizumab in caucasian patients
Treatment response to intravitreal bevacizumab in small pigmented choroidal lesions with subretinal fluid
Angiographic Review of Choroidal Involution in Eyes with Retinopathy of Prematurity Treated with Bevacizumab
Ethnic differences on long term outcomes of polypoidal choroidal vasculopathy after predominantly bevacizumab monotherapy
Paradoxical peeling patterns
Postoperative subconjunctival bevacizumab injection as an adjunct to 5-fluorouracil in the management of scarring after trabeculectomy
Postoperative subconjunctival bevacizumab injection as an adjunct to 5-fluorouracil in the management of scarring after trabeculectomy